1. Home
  2. IROQ vs INKT Comparison

IROQ vs INKT Comparison

Compare IROQ & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IROQ
  • INKT
  • Stock Information
  • Founded
  • IROQ 1883
  • INKT 2017
  • Country
  • IROQ United States
  • INKT United States
  • Employees
  • IROQ N/A
  • INKT N/A
  • Industry
  • IROQ Savings Institutions
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • IROQ Finance
  • INKT Health Care
  • Exchange
  • IROQ Nasdaq
  • INKT Nasdaq
  • Market Cap
  • IROQ 82.7M
  • INKT 69.2M
  • IPO Year
  • IROQ 2011
  • INKT 2021
  • Fundamental
  • Price
  • IROQ $26.03
  • INKT $11.14
  • Analyst Decision
  • IROQ
  • INKT Buy
  • Analyst Count
  • IROQ 0
  • INKT 2
  • Target Price
  • IROQ N/A
  • INKT $35.00
  • AVG Volume (30 Days)
  • IROQ 11.5K
  • INKT 21.8K
  • Earning Date
  • IROQ 10-31-2025
  • INKT 11-14-2025
  • Dividend Yield
  • IROQ 1.54%
  • INKT N/A
  • EPS Growth
  • IROQ 154.92
  • INKT N/A
  • EPS
  • IROQ 1.60
  • INKT N/A
  • Revenue
  • IROQ $27,979,000.00
  • INKT N/A
  • Revenue This Year
  • IROQ N/A
  • INKT N/A
  • Revenue Next Year
  • IROQ N/A
  • INKT N/A
  • P/E Ratio
  • IROQ $16.24
  • INKT N/A
  • Revenue Growth
  • IROQ 24.68
  • INKT N/A
  • 52 Week Low
  • IROQ $21.00
  • INKT $4.56
  • 52 Week High
  • IROQ $26.50
  • INKT $76.00
  • Technical
  • Relative Strength Index (RSI)
  • IROQ 58.97
  • INKT 28.19
  • Support Level
  • IROQ $25.70
  • INKT $13.13
  • Resistance Level
  • IROQ $25.86
  • INKT $14.20
  • Average True Range (ATR)
  • IROQ 0.15
  • INKT 0.78
  • MACD
  • IROQ 0.01
  • INKT -0.21
  • Stochastic Oscillator
  • IROQ 42.07
  • INKT 9.43

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: